Companies are being advised to learn the risks and opportunities associated with marketing pharmaceuticals in Asia.  See the complete story here.   According to a recent study by PricewaterhouseCoopers, the pharmaceutical companies need to get established in Asia to really understand the market and its dynamics.

In addition to this call to have an on-the-ground presence, protecting intellectual property is still a valid concern as more government regulation and protection is needed.   Governments are issuing various incentives to promote regional investment by pharmaceutical companies.

With an opportunity this great, how can a publicly-held pharmaceutical company not try to navigate the risk for its shareholders?

This entry was posted on Monday, August 20th, 2007 at 11:20 am and is filed under Health Care & Pharmaceuticals, Geographies, Corporate. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.